Last reviewed · How we verify

◦Drug: ASCs. + fibrin glue

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Phase 3 active Small molecule

◦Drug: ASCs. + fibrin glue is a Small molecule drug developed by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. It is currently in Phase 3 development. Also known as: Experimental Drug: ASCs + fibrin glue.

At a glance

Generic name◦Drug: ASCs. + fibrin glue
Also known asExperimental Drug: ASCs + fibrin glue
SponsorInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz
ModalitySmall molecule
PhasePhase 3

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ◦Drug: ASCs. + fibrin glue

What is ◦Drug: ASCs. + fibrin glue?

◦Drug: ASCs. + fibrin glue is a Small molecule drug developed by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz.

Who makes ◦Drug: ASCs. + fibrin glue?

◦Drug: ASCs. + fibrin glue is developed by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (see full Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz pipeline at /company/instituto-de-investigaci-n-sanitaria-de-la-fundaci-n-jim-nez-d-az).

Is ◦Drug: ASCs. + fibrin glue also known as anything else?

◦Drug: ASCs. + fibrin glue is also known as Experimental Drug: ASCs + fibrin glue.

What development phase is ◦Drug: ASCs. + fibrin glue in?

◦Drug: ASCs. + fibrin glue is in Phase 3.

Related